SU2C Health Equity Breakthrough Team Research Grant Program

Stand Up To Cancer (SU2C) invites applications for the SU2C Health Equity Breakthrough Team Research Grant Program. The Breakthrough Team represents an unprecedented opportunity to bring together the best scientific minds from diverse fields of research to concentrate on new approaches to address health equity in the context of cancer research. The goal of SU2C "health equity” is for patients of all racial and ethnic backgrounds to equally benefit from the potential of cancer treatments; and for cancer research to address remediable differences, i.e.,  genetics, biology, risk, incidence, and mortality, and barriers to participation, in order to attain comparable outcomes for all racial and ethnic populations. This Breakthrough Team will be unique in that it brings together key stakeholders that are deeply connected to the impacted communities and will integrate social/behavioral determinants of health and outreach with cancer biology, prevention, and treatment. The Breakthrough Team is supported by a transformational grant from Genentech, a member of the Roche Group.


  • Please submit* your “Letter of Intent” by Tuesday, September 1, 2020, at 12pm Noon EDT. Finalists will be invited on or before Thursday, October 1, 2020, to submit a full application due Friday, January 8, 2021.
  • The scale of a project should not exceed US $6 million total.
  • Teams are required to have a Team Leader, Team Co-Leader, Project Manager, and two Patient Advocates. Research must be carried out within the United States. There are no citizenship or residency status restrictions for team members.
  • Projects should be planned for four years with any proposed clinical trials completing accrual by the end of the grant period.


See this video for viewing more information about this program.


* SU2C is closely monitoring the rapidly evolving conditions related to the novel COVID-19 pandemic and the demands imposed on research institutions. SU2C is sensitive to the rapidly changing environment due to COVID-19, while seeking to sustain its ongoing commitment to accelerate cancer research so all cancer patients may live a quality life as long-term survivors. As such, the application deadlines and overall timeline presented in this Request for Applications may shift. The included timeline reflects “no sooner than” dates for deliverables. Interested applicants can see the latest schedule for deliverables at or can pose questions to

September 1, 2020

Subscribe to the UArizona Impact in Action newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.

Subscribe now